{"schema_version":"secwatch.filing_event.v1","accession":"0001058290-24-000325","form_type":"8-K","ticker":"CTSH","cik":"0001058290","company_name":"COGNIZANT TECHNOLOGY SOLUTIONS CORP","filed_at":"2024-10-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:07.528310+00:00","generated_at":"2026-05-30T07:58:18.324910+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Cognizant Q3 revenue $5.0B (+3% YoY) at guidance high end; 19 large deals YTD exceed full-year 2023","bullets":["Revenue $5.04B (+3.0% YoY, +2.7% constant currency) at high end of guidance.","GAAP diluted EPS $1.17; adjusted EPS $1.25; adjusted operating margin 15.3%.","Health Sciences +7.8% YoY; Financial Services returned to growth +0.7% YoY.","Trailing 12-month bookings $26.2B, book-to-bill 1.3x; six deals >$100M TCV in Q3.","Full-year 2024 CC revenue guidance narrowed to 1.4%-1.9% growth (midpoint unchanged); adjusted op margin ~15.1%."],"urls":{"canonical":"https://secwatch.observer/filing/0001058290-24-000325","json":"https://secwatch.observer/filing/0001058290-24-000325.json","markdown":"https://secwatch.observer/filing/0001058290-24-000325.md","text":"https://secwatch.observer/filing/0001058290-24-000325.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1058290/000105829024000325/0001058290-24-000325-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1058290/000105829024000325/ctsh-20241030.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T07:58:18.324910+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}